As shortages of GLP-1s have resolved and off-label usage has become increasingly common, a class of casual users has emerged not obese, not diabetic, not even overweight, and, often, not on the radar of doctors
F., Pecoraro, N
Analysis of FAERS data from 2004 to 2020 revealed significant associations between GLP-1 RA and various neoplasms, notably medullary thyroid cancer (PRR, 27.43), papillary thyroid cancer (PRR, 8.68), malignant pancreatic neoplasms (PRR, 9.86), and pancreatic neuroendocrine neoplasms (PRR, 2.86) [52]
Ozempic also contains semaglutide, but it is more closely associated with type 2 diabetes management, even though many people discuss it for weight loss
Supplementary Fig